AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, H.
Right arrow Articles by Brady, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, H.
Right arrow Articles by Brady, T. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

American Journal of Roentgenology, Vol 162, 1041-1046, Copyright © 1994 by American Roentgen Ray Society

ARTICLES

Detection of pulmonary emboli by using MR angiography with MPEG-PL- GdDTPA: an experimental study in rabbits

H Frank, R Weissleder, AA Bogdanov Jr and TJ Brady
Department of Radiology, Massachusetts General Hospital, Charlestown.

OBJECTIVE. A macromolecular MR contrast agent (MPEG-PL-GdDTPA), which consists of Gd-DTPA covalently attached to a polyamino acid (PL) derivatized by monomethoxy ether of polyethylene glycol (MPEG), has recently been developed. This contrast agent exhibits long intravascular retention, which makes it suitable for MR angiography. The current study was performed to test whether this agent would improve visualization of the pulmonary vasculature during MR angiography and whether it aids in the detection of pulmonary emboli in an animal model. MATERIALS AND METHODS. All experiments were performed in rabbits (n = 21), six of which were healthy and 15 of which had induced pulmonary emboli. Contrast-enhanced MR angiograms (0.02 mmol Gd/kg) were obtained at 1.5 T by using time-of-flight and phase- contrast sequences. MR images were ultimately compared with polymer casts of pulmonary arteries and/or pathologic sectioning. RESULTS. MR angiograms obtained before the administration of a contrast agent were of low quality primarily because of low vessel/background signal-to- noise ratio, presumably due to slow and complex flow in the pulmonary vasculature. After IV administration of the contrast agent, pulmonary arteries could be visualized up to the third-order branches. Of the 18 pathologically or angiographically proved emboli, 16 could be detected with contrast-enhanced MR angiography. CONCLUSION. Our results indicate that macromolecular contrast agents with long blood half-lives, such as MPEG-PL-GdDTPA, increase signal intensity of pulmonary vessels, improve the quality of MR angiography, and increase the detectability of pulmonary emboli.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Roentgen Ray Society.